Seed Capital Solutions #SCSP – Notice of GM. Form of Proxy
Seed Capital Solutions plc announces that as a direct result of the aborted acquisition of 4D Medica SA (“4DM”) (“Transaction”), the Company requires new funding by way of the issuance of new ordinary shares in the Company (“Shares”). The Company does not however, currently have the authority to issue sufficient Shares to satisfy its short-term working […]
Seed Capital Solutions #SCSP – Settlement with Creditors
Further to the Company’s announcement on 10 July 2026, the Company is pleased to announce that it has now reached agreement with all of its substantive creditors in respect of the settlement of outstanding liabilities. As previously announced, the Company had accrued adviser costs in respect of the initial transaction which was terminated on 10 […]
Seed Capital Solutions #SCSP – Termination of Potential Acquisition. Request for Lifting of Temporary Suspension
Termination of Proposed Acquisition The Company announces that the proposed acquisition of Cuarta Dimension Medica SL (“4DM”) in exchange for the issue of new ordinary shares in the Company (“Proposed Acquisition”) has been terminated. As announced on 29 June 2026, change of control provisions in respect of 4DM caused a delay to completion of the […]
Seed Capital Solutions Plc #SCSP – Update on Proposed Acquisition. Change of accounting reference date
Update on Proposed Acquisition As previously notified on 26 March 2026, the Company continues to work towards finalising the documentation required for the proposed acquisition of Cuarta Dimension Medica SL (“4DM”) in exchange for the issue of new ordinary shares in the Company (“Proposed Acquisition”) and admission of its enlarged issued share capital to trading […]
Seed Capital Solutions #SCSP – Update on Proposed Acquisition of the issued share capital of Cuarta Dimension Medica SL and Intention to seek Admission to Trading on AIM
As previously notified in the half-year report published on 9 March 2026, the Company continues to work towards finalising the documentation required for the proposed acquisition of Cuarta Dimension Medica SL (“4DM”) in exchange for the issue of new ordinary shares in the Company (“Proposed Acquisition”). Subject to completion of the Proposed Acquisition, the enlarged […]
Seed Capital Solutions #SCSP – Half Year Report
Seed Capital Solutions plc announces its unaudited half year report for the six months ended 31 December 2025. Chairman’s Statement During the financial period under review, the Company reported a net loss of £524,000 (December 2024: £158,000, year to 30 June 2025: £420,400), being the administrative expenses incurred net of other income of £33,600 in the […]
Seed Capital Solutions #SCSP – Result of AGM
Seed Capital Solutions plc (LON: SCSP), a Company formed for the purpose of acquiring a business or businesses operating in market sectors that can display strong ESG credentials, is pleased to announce that at today’s Annual General Meeting (“AGM”), Ordinary Resolutions 1-6 and Special Resolution 7 were all passed. -Ends FOR FURTHER INFORMATION, PLEASE CONTACT: […]
Seed Capital Solutions #SCSP – Annual Financial Report and Notice of AGM
Seed Capital Solutions plc (LON: SCSP) is pleased to announce its audited annual financial results for the financial year ended 30 June 2025. A notice to convene an Annual General Meeting at 10 am on 26 November 2025 will also be sent to shareholders with the annual Report and Accounts. The full audited financial accounts can […]
Seed Capital Solutions #SCSP – Proposed Acquisition of Cuarta Dimension Medica SL, Suspension of Listing and Appointment of Sponsor
Introduction Seed is pleased to announce that it has entered into non-binding heads of terms (“Heads”) and an exclusivity agreement with the shareholders of Cuarta Dimension Medica SL (“4DM”) for the acquisition (“Acquisition”) by the Company of all of the issued share capital of 4DM in exchange for the issue of new ordinary shares in the […]
Seed Capital Solutions Plc #SCSP – Issue of Warrants
Seed Capital Solutions plc (LON: SCSP) announces that the Company has issued a total of 17,000,000 warrants (“New Warrants”) over ordinary shares of 0.25 pence each (“Ordinary Shares”) to the Company’s Directors and Company Secretary, as detailed below. Name Role Number of warrants held prior to the issue of the New Warrants Number of New […]